Skip to content

Comparison of Mid-term Results of Total Correction of TOF Between Preservation of PV and Trans-annular Patch.

Comparison of Mid-term Results of Total Correction of Tetralogy of Fallot Between Preservation of Pulmonary Valve and Trans-annular Patching

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03732742
Enrollment
50
Registered
2018-11-07
Start date
2018-11-30
Completion date
2019-09-30
Last updated
2018-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tetrology of Fallot

Brief summary

To compare of mid-term results of total correction of tetralogy of fallot between preservation of pulmonary valve and trans-annular patching , thus avoiding PV regurgitation during TOF repair , this will determine the value of this procedure over trans-annular patching regarding to right ventricular performance.

Detailed description

Surgical repair of congenital lesions associated with right ventricular outflow tract obstruction frequently requires the destruction of pulmonary valve (PV) competents including the pulmonary annulas. The resulatnt pulmonary insufficiency may lead to late functional deterioration of right ventricular performance. Acute right ventricular dysfunction has been associated with poor pulmonary runoff, tricuspid valve regurgitaion and pulmonary hypertension. Preservation of PV comptence may prevent both early and late right ventricular failure. Total repair of tetralogy of fallot is a corrective surgical procedure that involves closure of the ventricular septal defect (VSD) and relief of right ventricular outflow tract (RVOT) obstruction. The surgeon must decide whether the right ventricular outflow tract size will be sufficient to allow for the entire cardiac output to traverse it without causing extreme elevation in right ventricular pressure or will go for trans-annular patch. Recently interest has shifted to preserving the integrity of the pulmonary valve annulus thus avoiding pulmonary valve regurgitation.

Interventions

PROCEDURETOF repair with trans-annular patch VS preservation of PV

One group study

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

1. Patients undergoing elective total correction of tetralogy of Fallot. 2. Any age group. 3. Normal pulmonay branches

Exclusion criteria

1. Patients associated with other congenital anomalies. 2. Regarding PV morphology, patients with pulmonary atresia , absence of PV. 3. Patients with anomalous coronary artery anatomy obstructs access to the RV 4. Extra-cardiac illness that is expected to limit survival to less than 5 years.e.g active hepatitis or significant hepatic or renal disorders.

Design outcomes

Primary

MeasureTime frameDescription
include median RVOT gradient and degree of PV stenosisOne week for preoperative assessment.Parameters will be measured include median RVOT gradient in mmhg , degree of PV stenosis by peak gradient across the PV in mmhg preoperatively
Oxygen saturation , RV functionOne week for preoperative assessment.Parameters will be measured include Oxygen saturation level % , RV function by measure RV fractional area changes (RVFAC) % preoperatively
GenderOne week for preoperative assessment.Parameters will be measured include gender preoperatively
HeightOne week for preoperative assessment.Parameters will be measured include height in meters preoperatively
Body weightOne week for preoperative assessment.Parameters will be measured include body weight in kilograms preoperatively
AgeOne week for preoperative assessmentParameters will be measured include age in months preoperatively
degree of PV regurge, degree of TR and RV sizeOne week for preoperative assessment.Parameters will be measured include degree of PV regurge jet size by color doppler,degree of TR by jet area -central jets in cm\^2 , RV size (RV diastolic area in cm\^ , RV systolic area in cm\^ ) preoperatively
PV annulus and PV z-scoreOne week for preoperative assessment.Parameters will be measured include median PV annulus diameter in mm , median PV Z-score diameter in mm preoperatively

Secondary

MeasureTime frameDescription
ICU stayPre-discharge postoperative assessment within one monthParameters will be measured include ICU stay days pre-discharge postoperative assessment.
Time till weaning from mechanical ventilatorPre-discharge postoperative assessment within one monthParameters will be measured include Time till weaning from mechanical ventilator in hours pre-discharge postoperative assessment.
AgePre-discharge postoperative assessment within one monthParameters will be measured include age in months pre-discharge postoperative assessment.
Median RVOT gradient and degree of PV stenosisPre-discharge postoperative assessment within one monthParameters will be measured include median RVOT gradient in mmhg , degree of PV stenosis by peak gradient across the PV in mmhg pre-discharge postoperative assessment.
PV annulus and PV z-scorePre-discharge postoperative assessment within one monthParameters will be measured include median PV annulus diameter in mm , median PV Z-score diameter in mm pre-discharge postoperative assessment.
GenderPre-discharge postoperative assessment within one monthParameters will be measured include gender pre-discharge postoperative assessment.
Body weightPre-discharge postoperative assessment within one monthParameters will be measured include body weight in kilograms pre-discharge postoperative assessment.
HeightPre-discharge postoperative assessment within one monthParameters will be measured include height in meters pre-discharge postoperative assessment.
Oxygen saturation , RV functionPre-discharge postoperative assessment within one monthParameters will be measured include Oxygen saturation level % , RV function by measure RV fractional area changes (RVFAC) % Pre-discharge postoperative assessment.
degree of PV regurge, degree of TR and RV sizePre-discharge postoperative assessment within one monthParameters will be measured include degree of PV regurge jet size by color doppler,degree of TR by jet area -central jets in cm\^2 , RV size (RV diastolic area in cm\^ , RV systolic area in cm\^ ) pre-discharge postoperative assessment.
Median cross clamp time and CPB timePre-discharge postoperative assessment within one monthParameters will be measured include Median cross clamp time in minutes and CPB time in minutes pre-discharge postoperative assessment.

Other

MeasureTime frameDescription
GenderReassessment after 6 months.Parameters will be measured include gender in follow up after 6 months.
AgeReassessment after 6 months.Parameters will be measured include age in months in follow up after 6 months.
degree of PV regurge, degree of TR and RV sizeReassessment after 6 months.Parameters will be measured include degree of PV regurge jet size by color doppler,degree of TR by jet area -central jets in cm\^2 , RV size (RV diastolic area in cm\^ , RV systolic area in cm\^ ) in follow up after 6 months.
PV annulus and PV z-scoreReassessment after 6 months.Parameters will be measured include median PV annulus diameter in mm , median PV Z-score diameter in mm in follow up after 6 months.
include median RVOT gradient and degree of PV stenosisReassessment after 6 months.Parameters will be measured include include median RVOT gradient in mmhg and degree of PV stenosis by peak gradient across the PV in mmhg in follow up after 6 months.
Oxygen saturation , RV functionReassessment after 6 months.Parameters will be measured include Oxygen saturation level % , RV function by measure RV fractional area changes (RVFAC) % in follow up after 6 months.
HeightReassessment after 6 months.Parameters will be measured include body height in meters in follow up after 6 months.
Body weightReassessment after 6 months.Parameters will be measured include body weight in kilograms in follow up after 6 months.

Contacts

Primary ContactShareef Al Shareef, Master
shareefaldesoky12@gmail.com+966533505988
Backup ContactHussein K El khayat, Lecturer
dr_khayat@hotmail.com+201005549653

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026